Michael Kors Holdings Limited’s (KORS) shares dropped over 12% during premarket hours on Wednesday after the company topped market estimates on earnings for the second quarter of 2019 but missed the mark on revenues.
Total revenues grew 9.3% to $1.25 billion from the year-ago period, including a $116.7 million contribution from Jimmy Choo, but came in shy of the Street estimate of $1.26 billion.
Reported net income dropped to $137.6 million or $0.91 per share from $202.9 million or $1.32 per share in the prior-year period. Adjusted net income was $192.5 million or $1.27 per share. Analysts had estimated earnings of $1.10 per share.
Michael Kors brand revenues fell 0.8% but came in line with the company’s expectations. Comparable store sales, which were down in the low single digits, were also in line with the firm’s expectations.
Jimmy Choo posted better-than-expected revenues, which were helped by strength in footwear. The company saw revenue declines across its Retail, Wholesale and Licensing segments. Inventory dropped 11% compared to the prior-year period.
During the quarter, Michael Kors announced an agreement to acquire Gianni Versace SPA for $2.1 billion. The transaction is expected to close in the fourth quarter of 2019 and following the acquisition, Michael Kors will change its name to Capri Holdings Limited and operate under the ticker CPRI.
For the full year of 2019, Michael Kors is raising its outlook for adjusted EPS by $0.05 to a range between $4.95 and $5.05, reflecting better-than-expected Q2 performance for the Michael Kors and Jimmy Choo brands. Revenue is expected to be around $5.12 billion, including between $580 million and $590 million of incremental Jimmy Choo revenue.
For the third quarter of 2019, Michael Kors expects total revenue to be about $1.46 billion, including approx. $165 million of incremental revenue from Jimmy Choo. Diluted EPS is expected to be $1.52 to $1.57, which includes approx. $0.04 to $0.06 of accretion from Jimmy Choo.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company started trading in double-digits after a long time.
Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states, at a time when its legalization is getting
Eastman Kodak (NYSE: KODK) reported a loss of $5 million on revenue of $213 million in the second quarter of 2020. The company earned $201 million in the prior-year quarter.